Relapse represents the main cause of treatment failure after allogeneic stem cell transplant
(allo-SCT). The detection of minimal residual disease (MRD) by multiparametric flow …

Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

Posttransplant leukemia detection before overt relapse is key to the success of
immunotherapeutic interventions, as they are more efficient when leukemia burden is low …

Background We report a routine flow cytometric (FACS) approach to quantify circulating
leukocytes (NC) in myeloablated patients before and during regeneration after allogeneic …

This prospective study evaluated the kinetics of lymphoid (CD3) engraftment in 110 patients
with acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) after allogeneic …

The generally dismal outcome of MDS relapse after allogeneic stem cell transplantation
(SCT) may improve with early detection and salvage interventions, such as withdrawal of …

Dear Editor, Allogeneic hematopoietic stem cell transplantation (HSCT) is an important
treatment modality for various malignant and non-malignant hematological disorders …

Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant
patient number of patients studied is limited and all transplant recipients received a dose …

Chimerism analysis is used to evaluate patients after allogeneic hematopoietic stem cell
transplant (allo-HSCT) for engraftment and minimal measurable residual disease (MRD) …

The increase of mixed chimerism (MC) after allogeneic hematopoietic stem cell
transplantation has been associated with a high risk of relapse. A variety of techniques that …